Barclays Downgrades Johnson & Johnson (JNJ) to Equalweight

(Updated - November 29, 2016 8:08 AM EST)

Barclays downgraded Johnson & Johnson (NYSE: JNJ) from Overweight to Equalweight with a price target of $125.00 (from $130.00). Analyst Geoff Meacham sees less compelling risk-reward.

For an analyst ratings summary and ratings history on Johnson & Johnson click here. For more ratings news on Johnson & Johnson click here.

Shares of Johnson & Johnson closed at $113.13 yesterday.

You May Also Be Interested In

• Stifel Downgrades Komax Holding AG (KOMN:SW) to Sell
• Deutsche Bank Downgrades Tesla (TSLA) to Hold, 'Considerable risk from “going balls to the wall for autonomy”'
• Rivian Automotive Inc (RIVN) PT Lowered to $13 at Needham on "slower EV adoption ahead of the R2 vehicle launch"